Ocular Surface Disease Treatments in the Pipeline - Poll - MDSpire

Ocular Surface Disease Treatments in the Pipeline

Potential treatments address inflammation and tear production, offer alternative mechanisms of action, or address a subset of dry eye.

  • By

  • Bela Parekh, MD

  • Jai G. Parekh, MD, MBA, FAAO

  • May 1, 2025

  • 7 min

Share

Original Source(s)

Ocular Surface Disease Treatments in the Pipeline

  • by Bela Parekh, MD, Jai G. Parekh, MD, MBA, FAAO

  • May 1, 2025

Related Content

Between the Snapshots: The Case for Continuous Engagement

Taking care of eye patients between visits

Precision treatment of chalazion based on AI-driven risk stratification: a prospective study of triamcinolone acetonide combined with intense pulsed light therapy

The Importance of Treating OSD and Lid Margin Disease Preoperatively

Marjan Farid, MD, discusses her ASCRS Cornea Day presentation on preoperatively treating DED and OSD.

  • April 11, 2026

  • 4 min